1. Fructose‐1,6‐bisphosphate induces generation of reactive oxygen species and activation of p53‐dependent cell death in human endometrial cancer cells
   Bruna Pasqualotto Costa et al, 2021, Journal of Applied Toxicology CrossRef
2. Fructose-1,6-bisphosphate decreases IL-8 levels and increases the activity of pro-apoptotic proteins in HepG2 cells
   Gabriele Catyana Krause et al, 2017, Biomedicine & Pharmacotherapy CrossRef
3. CPBMF65, a synthetic human uridine phosphorylase-1 inhibitor, reduces HepG2 cell proliferation through cell cycle arrest and senescence
   Elisa Feller Gonçalves da Silva et al, 2020, Investigational New Drugs CrossRef
4. The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer
   Dimakatso Alice Senthebane et al, 2017, International Journal of Molecular Sciences CrossRef
5. Targeting FBPase is an emerging novel approach for cancer therapy
   Gao-Min Liu et al, 2018, Cancer Cell International CrossRef
6. Fructose-1,6-Bisphosphate Prevents Bleomycin-Induced Pulmonary Fibrosis in Mice and Inhibits the Proliferation of Lung Fibroblasts
   Renan Trevisan Jost et al, 2018, Inflammation CrossRef
7. Autophagy: Dual Response in the Development of Hepatocellular Carcinoma
   Hamza Yazdani et al, 2019, Cells CrossRef
8. Fructose-1,6-bisphosphate prevents pulmonary fibrosis by regulating extracellular matrix deposition and inducing phenotype reversal of lung myofibroblasts
   Henrique Bregolin Dias et al, 2019, PLOS ONE CrossRef